5/9
© Forsa
According to the website of Center for Infectious Diseases Research and Policya center within the University of Minnesota focused on public health preparedness and emerging response to infectious diseases, “Compared to Pfizer, Moderna is slightly more effective in terms of protecting against infection as early as days after the second dose. This improves over time, with the need for vaccination. 1,047 People to prevent SARS-CoV-2 infection status after 30 days, a number that drops to 290 after 90 days”
Article on CIDRAP